Difference between revisions of "Goserelin (Zoladex)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Drugs FDA" to "[[Category:FDA") |
m (added package insert, links) |
||
| Line 1: | Line 1: | ||
==General information== | ==General information== | ||
| − | Class/mechanism: Gonadotropin-releasing hormone (GnRH) analog, inhibits pituitary gonadotropin secretion, which suppresses ovarian and testicular steroidogenesis<ref name="insert">[http:// | + | Class/mechanism: Gonadotropin-releasing hormone (GnRH) analog, inhibits pituitary gonadotropin secretion, which suppresses ovarian and testicular steroidogenesis<ref name="insert">[http://documents.tersera.com/zoladex-us/10.8mg_MagnumPI.pdf Goserelin (Zoladex) package insert]</ref><ref>[[Media:Goserelin.pdf | Goserelin (Zoladex) package insert (locally hosted backup)]]</ref> |
<br>Route: SC | <br>Route: SC | ||
<br>Extravasation: n/a | <br>Extravasation: n/a | ||
| Line 11: | Line 11: | ||
==Patient drug information== | ==Patient drug information== | ||
| + | *Patient counseling information can be found in the [http://documents.tersera.com/zoladex-us/10.8mg_MagnumPI.pdf package insert]<ref name="insert"></ref> | ||
*[http://chemocare.com/bio/goserelin.asp Goserelin (Zoladex) patient drug information (Chemocare)]<ref>[http://chemocare.com/bio/goserelin.asp Goserelin (Zoladex) patient drug information (Chemocare)]</ref> | *[http://chemocare.com/bio/goserelin.asp Goserelin (Zoladex) patient drug information (Chemocare)]<ref>[http://chemocare.com/bio/goserelin.asp Goserelin (Zoladex) patient drug information (Chemocare)]</ref> | ||
*[http://www.uptodate.com/contents/goserelin-patient-drug-information Goserelin (Zoladex) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/goserelin-patient-drug-information Goserelin (Zoladex) patient drug information (UpToDate)]</ref> | *[http://www.uptodate.com/contents/goserelin-patient-drug-information Goserelin (Zoladex) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/goserelin-patient-drug-information Goserelin (Zoladex) patient drug information (UpToDate)]</ref> | ||
Revision as of 22:01, 12 May 2019
General information
Class/mechanism: Gonadotropin-releasing hormone (GnRH) analog, inhibits pituitary gonadotropin secretion, which suppresses ovarian and testicular steroidogenesis[1][2]
Route: SC
Extravasation: n/a
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
Patient drug information
- Patient counseling information can be found in the package insert[1]
- Goserelin (Zoladex) patient drug information (Chemocare)[3]
- Goserelin (Zoladex) patient drug information (UpToDate)[4]
History of changes in FDA indication
- 12/29/1989: Initial FDA approval (label not available on Drugs @ FDA)
Also known as
- Brand names: Novgos, Zoladex